Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Cantor Fitzgerald
Fish and Richardson
UBS
Federal Trade Commission
Healthtrust
Fuji
Colorcon

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,699,609

« Back to Dashboard

Which drugs does patent 7,699,609 protect, and when does it expire?

Patent 7,699,609 protects ARESTIN and is included in one NDA.

This patent has thirteen patent family members in thirteen countries.
Summary for Patent: 7,699,609
Title:Dispensing apparatus and cartridge with deformable tip
Abstract: A device for the treatment of periodontal disease. The device includes a handle that has a configuration familiar to dental professionals and a cartridge that is locked into the handle when use, typically delivery of a composition to a periodontal pocket, is desired. The cartridge provides for effective delivery of compositions, such as agents, as its tip is deformable, typically from a circular to an oval shape so as to flatten. The deformation may be made either manually, by the dental professional, or upon contact with teeth or other tissues, whereby this flattened tip can penetrate deeply into periodontal pockets for quick and direct application of the composition, for example, therapeutic agents.
Inventor(s): Lawter; James R. (Yardley, PA), Lanzilotti; Michael G. (Newtown, PA), Bates; Mark (Westwood, MA), Hunter; Gregory H. (Dover, MA)
Assignee: Orapharma, Inc. (Warminster, PA)
Application Number:10/763,632
Patent Claim Types:
see list of patent claims
Device; Use;

Drugs Protected by US Patent 7,699,609

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Orapharma ARESTIN minocycline hydrochloride POWDER, EXTENDED RELEASE;DENTAL 050781-001 Feb 16, 2001 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,699,609

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,682,348 Dispensing apparatus and cartridge ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 7,699,609

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 2263596 ➤ Try a Free Trial
Portugal 2263596 ➤ Try a Free Trial
Japan 4749672 ➤ Try a Free Trial
Japan 2005521467 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Colorcon
Teva
Julphar
Fish and Richardson
Dow
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.